The key symptoms that tell you if you have Covid, Strep A, a cold or the flu
Millions of Brits have been feeling unwell in the week leading up to Christmas, with Covid, Strep A, colds and flu all spreading. Some people have been complaining of a particularly intense illness that isn't Covid - with some dubbing it the '2022 lurgy'.
It has prompted health experts at the UK Health Security Agency to urge anyone feeling unwell to avoid mixing with friends and family over Christmas. People are also encouraged to wear facemasks and wash their hands regularly, to avoid illnesses spreading. If you or your child is feeling unwell, here are some of the key symptoms to look out for with Covid, Strep A and flu.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Differences between Covid, Strep A, flu, and common cold including symptomsEvery year during the festive period millions of people fall ill, and while most may just have a common cold, others could be struck down with something more sinister
Read more »
Covid, cold, flu, Strep A and RSV symptoms - how to tell winter lurgies apartWinter is prime time for many different illnesses to spread around, so here are all the differences between symptoms.
Read more »
Is your cough a symptoms of a cold, Covid, flu or Strep A?Before you head home for Christmas, it’s worth working out whether that chesty cough is just a cold or a symptom of flu, Strep A or Covid.
Read more »
NHS ambulance trusts lost 160,000 working days to long Covid last yearNHS ambulance trusts lost 160,000 working days to long Covid last year 🗣️ “Frontline workers exposed themselves to the virus while saving others during the pandemic and the Government cannot continue to ignore their sacrifice' - Green MP CarolineLucas
Read more »
Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors - Journal of Translational MedicineBackground SARS-CoV2 can induce a strong host immune response. Many studies have evaluated antibody response following SARS-CoV2 infections. This study investigated the immune response and T cell receptor diversity in people who had recovered from SARS-CoV2 infection (COVID-19). Methods Using the nCounter platform, we compared transcriptomic profiles of 162 COVID-19 convalescent donors (CCD) and 40 healthy donors (HD). 69 of the 162 CCDs had two or more time points sampled. Results After eliminating the effects of demographic factors, we found extensive differential gene expression up to 241 days into the convalescent period. The differentially expressed genes were involved in several pathways, including virus-host interaction, interleukin and JAK-STAT signaling, T-cell co-stimulation, and immune exhaustion. A subset of 21 CCD samples was found to be highly “perturbed,” characterized by overexpression of PLAU, IL1B, NFKB1, PLEK, LCP2, IRF3, MTOR, IL18BP, RACK1, TGFB1, and others. In addition, one of the clusters, P1 (n = 8) CCD samples, showed enhanced TCR diversity in 7 VJ pairs (TRAV9.1_TCRVA_014.1, TRBV6.8_TCRVB_016.1, TRAV7_TCRVA_008.1, TRGV9_ENST00000444775.1, TRAV18_TCRVA_026.1, TRGV4_ENST00000390345.1, TRAV11_TCRVA_017.1). Multiplexed cytokine analysis revealed anomalies in SCF, SCGF-b, and MCP-1 expression in this subset. Conclusions Persistent alterations in inflammatory pathways and T-cell activation/exhaustion markers for months after active infection may help shed light on the pathophysiology of a prolonged post-viral syndrome observed following recovery from COVID-19 infection. Future studies may inform the ability to identify druggable targets involving these pathways to mitigate the long-term effects of COVID-19 infection. Trial Registration: https://clinicaltrials.gov/ct2/show/NCT04360278 Registered April 24, 2020.
Read more »
Loss of Y in leukocytes as a risk factor for critical COVID-19 in men - Genome MedicineBackground The COVID-19 pandemic, which has a prominent social and economic impact worldwide, shows a largely unexplained male bias for the severity and mortality of the disease. Loss of chromosome Y (LOY) is a risk factor candidate in COVID-19 due to its prior association with many chronic age-related diseases, and its impact on immune gene transcription. Methods Publicly available scRNA-seq data of PBMC samples derived from male patients critically ill with COVID-19 were reanalyzed, and LOY status was added to the annotated cells. We further studied LOY in whole blood for 211 COVID-19 patients treated at intensive care units (ICU) from the first and second waves of the pandemic. Of these, 139 patients were subject to cell sorting for LOY analysis in granulocytes, low-density neutrophils (LDNs), monocytes, and PBMCs. Results Reanalysis of available scRNA-seq data revealed LDNs and monocytes as the cell types most affected by LOY. Subsequently, DNA analysis indicated that 46%, 32%, and 29% of critically ill patients showed LOY above 5% cut-off in LDNs, granulocytes, and monocytes, respectively. Hence, the myeloid lineage that is crucial for the development of severe COVID-19 phenotype is affected by LOY. Moreover, LOY correlated with increasing WHO score (median difference 1.59%, 95% HDI 0.46% to 2.71%, p=0.025), death during ICU treatment (median difference 1.46%, 95% HDI 0.47% to 2.43%, p=0.0036), and history of vessel disease (median difference 2.16%, 95% HDI 0.74% to 3.7%, p=0.004), among other variables. In 16 recovered patients, sampled during ICU stay and 93–143 days later, LOY decreased significantly in whole blood and PBMCs. Furthermore, the number of LDNs at the recovery stage decreased dramatically (median difference 76.4 per 10,000 cell sorting events, 95% HDI 55.5 to 104, p=6e−11). Conclusions We present a link between LOY and an acute, life-threatening infectious disease. Furthermore, this study highlights LOY as the most prominent clonal mutation affe
Read more »